Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies.
Yap TA; Olmos D; Brunetto AT; Tunariu N; Barriuso J; Riisnaes R; Pope L; Clark J; Futreal A; Germuska M; Collins D; deSouza NM; Leach MO; Savage RE; Waghorne C; Chai F; Garmey E; Schwartz B; Kaye SB; de Bono JS; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2011, vol. 29, issue 10, p 1271, ISSN 15277755. ISBN 15277755.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef